<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01236820</url>
  </required_header>
  <id_info>
    <org_study_id>CTCHANG001</org_study_id>
    <nct_id>NCT01236820</nct_id>
  </id_info>
  <brief_title>A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients</brief_title>
  <acronym>L5</acronym>
  <official_title>L5 as a Risk Factor of Cardiovascular Disease in Chronic Kidney Disease and Dialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether L5, one of the Low Density Lipoproteins, is
      an effective predicting factor for cardiovascular disease in chronic renal and hemodialytic
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease (CVD) is the most important cause of death of chronic kidney disease
      (CKD) and hemodialysis (HD) patients. Low Density Lipoprotein (LDL) is an essential indicator
      of CVD.The higher the plasma LDL level, the higher the risk of CVD. LDL is a heterogenous
      substance composed of different mass and size. Oxidized LDL (oxLDL) is the oxidation product
      of LDL and is the most important component of LDL associated with CVD. The oxLDL is mostly
      trapped within tissue and not easily to be detected from blood. L5 iw a kind of
      electronegative LDL and is associated with CVD in smokers and diabetic patients, even if
      these patients have normal plasma LDL. Uremia patients have lipid profile different from that
      of general people,while HD Patients have lower LDL and CKD patients have LDL higher than that
      of general population. Thus LDL plasma level cannot fully explain the high risk of CVD in CKD
      and HD patients. As patients with normal LDL but high L5 are prone to have CVD, we suspect
      there might be association of L5 with CVD in both CKD and HD patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Cardiovascular Disease</condition>
  <condition>Chronic Kidney Disease Patients</condition>
  <condition>Hemodialytic Patients</condition>
  <condition>High LDL Level</condition>
  <condition>High L5 Level</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>Healthy population</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CKD Patients</arm_group_label>
    <description>Chronic Kidney Disease, in Stage III-V</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HD patients</arm_group_label>
    <description>End-stage renal disease patients undergoing hemodialysis</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Residents in Taiwan, mostly in Taichung area
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of CKD

          -  clinical diagnosis of HD

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chiz-Tzung Chang, Ph.D.</last_name>
    <phone>886-4-22052121</phone>
    <phone_ext>2902</phone_ext>
    <email>D19863@mail.cmuh.org.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chiu-Ching Huang, MD</last_name>
    <phone>886-4-22052121</phone>
    <phone_ext>2902</phone_ext>
    <email>cch@mail.cmuh.org.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>China Medical University Hospital</name>
      <address>
        <city>Taichung City</city>
        <zip>404</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiu-Ching Huang, MD</last_name>
      <phone>886-4-22052121</phone>
      <phone_ext>2902</phone_ext>
      <email>cch@mail.cmuh.org.tw</email>
    </contact>
    <contact_backup>
      <last_name>Chiz-Tzung Chang, MD, Ph.D.</last_name>
      <phone>886-4-22052121</phone>
      <phone_ext>2902</phone_ext>
      <email>D19863@mail.cmuh.org.tw</email>
    </contact_backup>
    <investigator>
      <last_name>Chiu-Ching Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2010</study_first_submitted>
  <study_first_submitted_qc>November 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2010</study_first_posted>
  <last_update_submitted>November 8, 2010</last_update_submitted>
  <last_update_submitted_qc>November 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Chiu-Ching Huang</name_title>
    <organization>China Medical University Hospital</organization>
  </responsible_party>
  <keyword>L5</keyword>
  <keyword>LDL</keyword>
  <keyword>Cardiovascular disease</keyword>
  <keyword>Chronic kidney disease</keyword>
  <keyword>Hemodialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

